prikaz prve stranice dokumenta MOLEKULARNA DIJAGNOSTIKA HEPATITISA C
  Download
PDF 70.46 KB
Professional paper - Review paper
MOLEKULARNA DIJAGNOSTIKA HEPATITISA C
Medicina Fluminensis : Medicina Fluminensis, 43. (2007), 2.; 132-137. urn:nbn:hr:184:528368
Grahovac, Blaženka; Hadžisejdić, Ita

Cite this document

Grahovac, B. & Hadžisejdić, I. (2007). MOLEKULARNA DIJAGNOSTIKA HEPATITISA C. Medicina Fluminensis : Medicina Fluminensis, 43.. (2.), 132-137. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:528368

Grahovac, Blaženka and Ita Hadžisejdić. "MOLEKULARNA DIJAGNOSTIKA HEPATITISA C." Medicina Fluminensis : Medicina Fluminensis, vol. 43., no. 2., 2007, pp. 132-137. https://urn.nsk.hr/urn:nbn:hr:184:528368

Grahovac, Blaženka and Ita Hadžisejdić. "MOLEKULARNA DIJAGNOSTIKA HEPATITISA C." Medicina Fluminensis : Medicina Fluminensis 43., no. 2. (2007): 132-137. https://urn.nsk.hr/urn:nbn:hr:184:528368

Grahovac, B. and Hadžisejdić, I. (2007) 'MOLEKULARNA DIJAGNOSTIKA HEPATITISA C', Medicina Fluminensis : Medicina Fluminensis, 43.(2.), pp. 132-137. Available at: https://urn.nsk.hr/urn:nbn:hr:184:528368 (Accessed 17 April 2024)

Grahovac B, Hadžisejdić I. MOLEKULARNA DIJAGNOSTIKA HEPATITISA C. Medicina Fluminensis : Medicina Fluminensis [Internet]. 2007 June 25 [cited 2024 April 17];43.(2.):132-137. Available at: https://urn.nsk.hr/urn:nbn:hr:184:528368

B. Grahovac and I. Hadžisejdić, "MOLEKULARNA DIJAGNOSTIKA HEPATITISA C", Medicina Fluminensis : Medicina Fluminensis, vol. 43., no. 2., pp. 132-137, June 2007. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:528368. [Accessed: 17 April 2024]

Please login to the repository to save this object to your list.
Metadata
Title (croatian)MOLEKULARNA DIJAGNOSTIKA HEPATITISA C
Title (english)MOLECULAR DIAGNOSIS OF HEPATITIS C INFECTION
AuthorBlaženka Grahovac
AuthorIta Hadžisejdić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of General Pathology and Pathological Anatomy)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (croatian)
SAŽETAK Svjetska zdravstvena organizacija (WHO) prepoznala je hepatitis C kao svjetski problem. Na osnovi procjena iz godine 1999., 170 milijuna ljudi bilo je kronično inficirano hepatitis C virusom (HCV). HCV vodeći je čimbenik neizlječivih oboljenja jetre, uključujući karcinom jetre. Za otkriće HCV-a godine 1989., zaslužni su molekularno-biološki postupci na kojima se zasniva suvremena dijagnostika hepatitisa C. Dijagnostički testovi dijele se na serološke testove kojima se dokazuju anti-HCV protutijela, te na molekularne testove kojima se u inficirane osobe dokazuje, određuje i obilježuje HCV-RNA genom. Kvalitativni molekularni testovi primjenjuju se za potvrđivanje infekcije, te u kontroli darivane krvi. Praćenjem broja virusnih kopija, kvantitativni HCV-RNA testovi daju podatke o odgovoru na antivirusnu terapiju. HCV jest heterogeni virus koji se na osnovi genomske promjenljivosti svrstava u 6 osnovnih genotipova, te u više podtipova. HCV genotipizacija bitna je za kliničara, budući da se prema pojedinome genotipu može procijeniti odgovor na antivirusnu terapiju, a određivanjem HCV genotipa odabire se optimalni terapijski postupak vezan uz duljinu razdoblja terapije i dozu ribavirina.
Abstract (english)
ABSTRACT The World Health Organization recognized hepatitis C (HCV) as a global health problem estimated that in 1999, over 170 million people were chronically infected with HCV. HCV is leading cause of end-stage liver disease and hepatocellular carcinoma. The discovery of hepatitis C virus (HCV) in 1989 using molecular biology methods has led to the rapid evolution of the field of HCV diagnostics. Diagnostic tests for HCV can be divided into serological assays that detect antibody to HCV and molecular assays that detect, quantify and characterize HCV-RNA genome within infected patient. Qualitative molecular nucleic acid tests are used for confirmation of HCV infection and for screening blood donation. Quantitative HCV-RNA tests provide prognostic information for monitoring the response to antiviral therapy. HCV is heterogeneous virus with six distinct genotypes and numerous subtypes. HCV genotype tests are important clinically because they predict most accurately the chance of antiviral response and are routinely used for selecting treatment regimens regarding the duration of interferon therapy and ribavirin dosage.
Keywords (croatian)
Keywords (english)
Languagecroatian
Publication typeProfessional paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleMedicina Fluminensis : Medicina Fluminensis
Numberingvol. 43., no. 2., pp. 132-137
p-ISSN0025-7729
URN:NBNurn:nbn:hr:184:528368
Publication2007-06-25
Document URLhttp://hrcak.srce.hr/22565
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2017-04-27 16:27:46